uniQure (QURE) Non Operating Interest Expenses (2016 - 2026)
Powered by 
Analysis
uniQure (QURE) Non Operating Interest Expenses (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 20.27 Mn |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | 14.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.37 Mn |
| Mar 31, 2026 | 14.03 Mn |
| Dec 31, 2025 | 14.57 Mn |
| Sep 30, 2025 | 16.72 Mn |
| Jun 30, 2025 | 15.59 Mn |
| Mar 31, 2025 | 15.11 Mn |
| Dec 31, 2024 | 14.88 Mn |
| Sep 30, 2024 | 16.61 Mn |
| Jun 30, 2024 | 16.16 Mn |
| Mar 31, 2024 | 16.10 Mn |
| Dec 31, 2023 | 15.71 Mn |
| Sep 30, 2023 | 15.44 Mn |
| Jun 30, 2023 | 6.84 Mn |
| Mar 31, 2023 | 3.56 Mn |
| Dec 31, 2022 | 3.43 Mn |
| Sep 30, 2022 | 3.07 Mn |
| Jun 30, 2022 | 2.69 Mn |
| Mar 31, 2022 | 2.52 Mn |
| Dec 31, 2021 | 2.10 Mn |
| Sep 30, 2021 | 1.92 Mn |